TScan Therapeutics TCRX SEC Filings

NASDAQ TCRX
$0.14 -0.01 (-6.67%)
At close: Nov 19, 2026 · 4:00 PM EST
EDGAR Disclosures

Latest SEC Filings

Latest filing 10-Q ·
Source SEC EDGAR

TScan Therapeutics (TCRX) has filed 336 documents with the SEC since July 2019, all on EDGAR under CIK 1783328. In the last 12 months it filed 42, including 1 annual report (10-K), 3 quarterly reports (10-Q), 14 current reports (8-K) and 14 insider filings (Form 4). The latest, a quarterly report (10-Q), was filed on Nov 12, 2026.

Form Type
# Form Type Description Accession Filed Filing Index
110-QQuarterly report · quarter ended Sep 30, 20260001193125-26-456919Nov 12, 2026 7:15 AM ET
28-KCurrent report: earnings results0001193125-26-456865Nov 12, 2026 7:00 AM ET
3DEF 14AProxy statement0001193125-26-431045Oct 26, 2026 8:07 AM ET
4PRE 14APreliminary proxy statement0001193125-26-424240Oct 16, 2026 9:03 PM ET
58-KCurrent report: director or officer change0001193125-26-424198Oct 16, 2026 8:45 PM ET
64Insider transaction0001193125-26-412521Oct 2, 2026 8:46 PM ET
74Insider transaction0001193125-26-412518Oct 2, 2026 8:45 PM ET
88-KCurrent report: director or officer change0001193125-26-409199Sep 30, 2026 5:00 PM ET
9SCHEDULE 13G5%+ passive stake0002063423-26-000002Sep 25, 2026 4:12 PM ET
108-KCurrent report: director or officer change0001193125-26-388631Sep 11, 2026 8:00 AM ET
118-KCurrent report: exit or restructuring costs, listing standard notice, director or officer change, Reg FD disclosure, other events0001193125-26-379343Sep 2, 2026 7:22 AM ET
128-KCurrent report: agreement ended0001193125-26-355664Aug 18, 2026 5:00 PM ET
13SCHEDULE 13G5%+ passive stake0000902664-26-003526Aug 14, 2026 4:33 PM ET
14SCHEDULE 13G5%+ passive stake0000921895-26-002183Aug 14, 2026 4:19 PM ET
1510-QQuarterly report · quarter ended Jun 30, 20260001193125-26-345749Aug 12, 2026 7:30 AM ET
168-KCurrent report: earnings results0001193125-26-345732Aug 12, 2026 7:15 AM ET
178-KCurrent report: Reg FD disclosure, other events0001193125-26-276693Jun 22, 2026 7:09 AM ET
184Insider transaction0001193125-26-236870May 22, 2026 4:08 PM ET
198-KCurrent report: charter or bylaw change, shareholder vote results0001193125-26-236862May 22, 2026 4:05 PM ET
204Insider transaction0001193125-26-236855May 22, 2026 4:05 PM ET
214Insider transaction0001193125-26-236854May 22, 2026 4:05 PM ET
224Insider transaction0001193125-26-236848May 22, 2026 4:05 PM ET
234Insider transaction0001193125-26-236844May 22, 2026 4:05 PM ET
244Insider transaction0001193125-26-236841May 22, 2026 4:05 PM ET
25SCHEDULE 13G5%+ passive stake0000921895-26-001399May 15, 2026 4:13 PM ET
2610-QQuarterly report · quarter ended Mar 31, 20260001193125-26-207572May 6, 2026 7:30 AM ET
278-KCurrent report: earnings results0001193125-26-207549May 6, 2026 7:15 AM ET
28ARSAnnual report to shareholders0001193125-26-160310Apr 17, 2026 7:32 AM ET
29DEF 14AProxy statement0001193125-26-160304Apr 17, 2026 7:30 AM ET
30PRE 14APreliminary proxy statement0001193125-26-145614Apr 7, 2026 4:30 PM ET
318-KCurrent report: director or officer change0001193125-26-138973Apr 2, 2026 7:30 AM ET
32S-8Employee stock plan registration0001193125-26-089915Mar 4, 2026 7:42 AM ET
3310-KAnnual report · fiscal year ended Dec 31, 20250001193125-26-089884Mar 4, 2026 7:30 AM ET
348-KCurrent report: earnings results0001193125-26-089871Mar 4, 2026 7:15 AM ET
354Insider transaction0001193125-26-019729Jan 22, 2026 5:52 PM ET
364Insider transaction0001193125-26-019723Jan 22, 2026 5:48 PM ET
374Insider transaction0001193125-26-019702Jan 22, 2026 5:30 PM ET
384Insider transaction0001193125-26-019697Jan 22, 2026 5:27 PM ET
394Insider transaction0001193125-26-019674Jan 22, 2026 5:19 PM ET
408-KCurrent report: Reg FD disclosure0001193125-26-009771Jan 12, 2026 7:30 AM ET
414Insider transaction0000902664-25-005396Dec 23, 2025 6:17 PM ET
428-KCurrent report: director or officer change0001193125-25-300538Nov 26, 2025 4:15 PM ET
4310-QQuarterly report · quarter ended Sep 30, 20250001193125-25-275933Nov 12, 2025 7:30 AM ET
448-KCurrent report: earnings results0001193125-25-275889Nov 12, 2025 7:15 AM ET
458-KCurrent report: exit or restructuring costs, Reg FD disclosure, other events0001193125-25-261612Nov 3, 2025 6:35 AM ET
468-KCurrent report: Reg FD disclosure0001193125-25-198768Sep 9, 2025 7:00 AM ET
473Initial insider ownership0001193125-25-186427Aug 22, 2025 4:10 PM ET
488-KCurrent report: director or officer change0001193125-25-184083Aug 20, 2025 4:10 PM ET
49SCHEDULE 13G5%+ passive stake0000902664-25-003579Aug 14, 2025 7:06 AM ET
50SCHEDULE 13G5%+ passive stake0000902664-25-003515Aug 12, 2025 9:07 AM ET
...

TScan Therapeutics SEC Filings API

Pull TScan Therapeutics's SEC filing index, with links to every filing and exhibit, into your own tools with the Business Quant SEC Filings API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/secfilings?ticker=TCRX&formtype=10-K,10-Q&api_key=YOUR_API_KEY

TScan Therapeutics SEC filings: questions

What is TScan Therapeutics's CIK number?

TScan Therapeutics's Central Index Key (CIK) is 1783328, written 0001783328 in EDGAR's ten-digit form. The SEC files every TScan Therapeutics filing under this number.

When did TScan Therapeutics file its latest 10-K and 10-Q?

Its latest annual report, the 10-K for the fiscal year ended Dec 31, 2025, was filed on Mar 4, 2026; its latest quarterly report, the 10-Q for the quarter ended Sep 30, 2026, was filed on Nov 12, 2026.

How often does TScan Therapeutics file with the SEC?

TScan Therapeutics made 42 SEC filings in the last 12 months, most often 14 Form 4 filings, 14 8-K filings and 4 SCHEDULE 13G filings. The most recent, a quarterly report (10-Q), was filed on Nov 12, 2026.

Is there an API for TScan Therapeutics's SEC filings?

Yes. The Business Quant SEC Filings API returns TScan Therapeutics's filing index (336 filings), with links to every filing and exhibit on EDGAR: /secfilings?ticker=TCRX. Free API keys are available. SEC Filings API docs